You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Vyxeos liposomal

Showing 1 - 25 of 738
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

iN the Real Practice

Not yet recruiting
  • Acute Myeloid Leukemia (AML)
  • +2 more
  • Vyxeos liposomal
  • Roma, Italy
    Policlinico Tor Vergata
Nov 16, 2023

Myeloid Tumor Trial in Memphis (CPX-351, MHA)

Recruiting
  • Myeloid Neoplasm
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Jan 20, 2023

Acute Myeloid Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia, Chronic Myelomonocytic Leukemia Trial in Chapel

Recruiting
  • Acute Myeloid Leukemia
  • +5 more
  • Biospecimen Collection
  • +3 more
  • Baltimore, Maryland
  • +2 more
Jan 19, 2023

Acute Myeloid Leukemia Trial in United States (Cytarabine, Idarubicin, Daunorubicin)

Recruiting
  • Acute Myeloid Leukemia
  • Duarte, California
  • +6 more
Nov 16, 2022

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, High Risk

Recruiting
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • +5 more
  • Gemtuzumab Ozogamicin
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022

Recurrent Acute Myeloid Leukemia Trial in United States (Enasidenib Mesylate, Liposome-encapsulated Daunorubicin-Cytarabine)

Suspended
  • Recurrent Acute Myeloid Leukemia
  • Enasidenib Mesylate
  • Liposome-encapsulated Daunorubicin-Cytarabine
  • Los Angeles, California
  • +3 more
Sep 27, 2022

Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Philadelphia (Palbociclib, Tazemetostat,

Not yet recruiting
  • Recurrent Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • Philadelphia, Pennsylvania
    Thomas Jefferson University Hospital
Jan 13, 2023

Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial (Azacitidine, Biospecimen Collection, Bone Marrow Aspiration)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome
  • (no location specified)
Jan 13, 2023

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia Arising

Not yet recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • (no location specified)
Nov 8, 2022

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Refractory Acute

Recruiting
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • +3 more
  • Gemtuzumab Ozogamicin
  • Liposome-encapsulated Daunorubicin-Cytarabine
  • Houston, Texas
    M D Anderson Cancer Center
Jun 2, 2021

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Tumor, Acute Myeloid

Not yet recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • (no location specified)
Nov 15, 2022

MDS, AML Trial in Austria, Germany (CPX-351, Daunorubicin, Cytarabine)

Recruiting
  • MDS
  • AML
  • Linz, Austria
  • +26 more
Sep 9, 2022

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Secondary Acute Myeloid Leukemia

Completed
Has Results
  • Acute Myeloid Leukemia
  • +2 more
  • Laboratory Biomarker Analysis
  • Liposome-encapsulated Daunorubicin-Cytarabine
  • Houston, Texas
    M D Anderson Cancer Center
Jan 8, 2021

Leukemia, Myeloid, Acute Trial in Jerusalem (Vyxeos, Mylotarg)

Recruiting
  • Leukemia, Myeloid, Acute
  • Jerusalem, Yerushalayim, Israel
    Shaare Zedek Medical Center
Oct 25, 2022

Acute Myeloid Leukemia Trial in Tianjin ((cytarabine: daunorubicin) liposome for injection, Vyxeos)

Not yet recruiting
  • Acute Myeloid Leukemia
  • (cytarabine: daunorubicin) liposome for injection
  • Vyxeos
  • Tianjin, China
    Institute of Hematology and Hospital of Blood Disease, Chinese A
Mar 24, 2023

Acute Myeloid Leukemia With FLT3/ITD Mutation Trial in Tampa (Gilteritinib, Vyxeos)

Suspended
  • Acute Myeloid Leukemia With FLT3/ITD Mutation
  • Tampa, Florida
    Moffitt Cancer Center
Nov 11, 2022

Blasts More Than 5 Percent of Bone Marrow Nucleated Cells, Persistent Disease, Refractory Acute Myeloid Leukemia Trial in

Unknown status
  • Blasts More Than 5 Percent of Bone Marrow Nucleated Cells
  • +2 more
  • Liposome-encapsulated Daunorubicin-Cytarabine
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Aug 6, 2019

Leukemia, Myeloid, Acute Trial (HDM201, cytarabine, anthracycline)

Withdrawn
  • Leukemia, Myeloid, Acute
  • (no location specified)
Jan 6, 2020

Leukemia Trial in Cincinnati (Vyxeos, Venetoclax)

Suspended
  • Leukemia
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Sep 21, 2022

Lymphoid Leukemia, Acute Lymphoblastic Leukemia, Refractory Acute Lymphoblastic Leukemia Trial in Tampa (CPX-351)

Active, not recruiting
Has Results
  • Lymphoid Leukemia
  • +3 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Dec 30, 2022

Acute Myeloid Leukemia (AML) Trial in France

Not yet recruiting
  • Acute Myeloid Leukemia (AML)
    • Amiens, France
    • +28 more
    Jul 21, 2021

    Rotator Cuff Tears, Postoperative Pain, Opioid Use Trial in Camden (Exparel Injectable Solution, Bupivacaine Injectable

    Enrolling by invitation
    • Rotator Cuff Tears
    • +2 more
    • Exparel Injectable Solution
    • Bupivacaine Injectable Solution
    • Camden, New Jersey
      Cooper University Hospital
    Nov 14, 2023

    Rhabdomyosarcoma Trial in Palo Alto, Memphis, Fort Worth (Vincristine, Dactinomycin, Cyclophosphamide)

    Not yet recruiting
    • Rhabdomyosarcoma
    • Palo Alto, California
    • +2 more
    Aug 27, 2023

    Acute Myeloid Leukemia Trial in Canada, Puerto Rico, United States (procedure, drug, behavioral)

    Recruiting
    • Acute Myeloid Leukemia
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +13 more
    • Birmingham, Alabama
    • +187 more
    Apr 28, 2022

    Liposomal Bupivacaine, Postoperative Recovery, Unilateral Knee Arthroplasty Trial in Nanjing (Nerve block with ropivacaine and

    Recruiting
    • Liposomal Bupivacaine
    • +2 more
    • Nerve block with ropivacaine and intravenous analgesia
    • +2 more
    • Nanjing, Jiangsu, China
      Nanjing First Hospital
    Nov 20, 2023